Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: Front Oncol ✕ 2022 ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients. PMID 35425715	Front Oncol	2022	53	L1 53/100
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. ⚑ PMID 35311085	Front Oncol	2022	30	L1 30/100 ⚑

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.

PMID 35425715 · Front Oncol · 2022

L1 53/100

Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.⚑

PMID 35311085 · Front Oncol · 2022

L1 30/100 ⚑